Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00147446 · ClinicalTrials.gov registry record · Phase 2
Stress Management for Patients With Multiple Sclerosis
A Phase 2 study of Multiple Sclerosis, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 121
- Enrollment target
- 3
- Study locations
NCT00147446 is a Phase 2 study of Multiple Sclerosis that has completed, run by Northwestern University. The registered enrollment target is 121 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00147446, a Phase 2 study of Multiple Sclerosis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 121 participants
- Enrollment target
- 3
- Study locations
Study Summary
There is a growing body of literature showing that stressful life events can increase the risk of developing exacerbations and new brain lesions among people with multiple sclerosis. The purpose of this study is to examine the hypothesis that stress management programs can reduce the occurrence of new brain lesions and exacerbations. We will also examine potential immune and neuroendocrine pathways.
Conditions Studied
Interventions
- BEHAVIORAL Individual Stress Management
- OTHER Wait List Control
Study Locations (3)
California
- UCSF Behavioral Medicine Research Center - San Francisco
Illinois
- Northwestern University, Department of Preventive Medicine - Chicago
Washington
- MS Center at Evergreen Medical Center - Kirkland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00147446
The ClinicalTrials.gov registry entry for NCT00147446 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (79% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Individual Stress Management is the first listed.
NCT00147446 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Washington.
Frequently Asked Questions
What is clinical trial NCT00147446 about?
NCT00147446 is a clinical study titled "Stress Management for Patients With Multiple Sclerosis". There is a growing body of literature showing that stressful life events can increase the risk of developing exacerbations and new brain lesions among people with multiple sclerosis. The purpose of this study is to examine the hypothesis that stress management programs can reduce the occurrence of n...
What is the current status of trial NCT00147446?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 121 participants. The study started on 2005-05. Estimated completion is 2009-01.
What conditions does trial NCT00147446 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT00147446?
The interventions under investigation include: Individual Stress Management (BEHAVIORAL), Wait List Control (OTHER).
Who is sponsoring clinical trial NCT00147446?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00147446 being conducted?
This trial has 3 study locations across California, Illinois, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
RECRUITING · Phase 2
-
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
RECRUITING · Phase 2
-
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
RECRUITING · Phase 2
-
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
RECRUITING · Phase 2
-
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.